Health Care Resource Utilization and Costs Associated With COVID-19 Among Pediatrics Managed in the Community or Hospital Setting in England: A Population-based Cohort Study.
Journal
The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858
Informations de publication
Date de publication:
18 Dec 2023
18 Dec 2023
Historique:
medline:
19
12
2023
pubmed:
19
12
2023
entrez:
19
12
2023
Statut:
aheadofprint
Résumé
Although COVID-19 morbidity is significantly lower in pediatrics than in adults, the risk of severe COVID-19 may still pose substantial health care resource burden. This study aimed to describe health care resource utilization (HCRU) and costs associated with COVID-19 in pediatrics 1-17 years old in England. A population-based retrospective cohort study of pediatrics with COVID-19 using Clinical Practice Research Datalink (CPRD Aurum) primary care data and, where available, linked Hospital Episode Statistics Admitted Patient Care secondary care data. HCRU and associated costs to the National Health Service were stratified by age, risk of severe COVID-19 and immunocompromised status, separately for those with and without hospitalization records (hospitalized cohort: COVID-19 diagnosis August 2020-March 2021; primary care cohort: COVID-19 diagnosis August 2020-January 2022). This study included 564,644 patients in the primary care cohort and 60 in the hospitalized cohort. Primary care consultations were more common in those 1-4 years of age (face-to-face: 4.3%; telephone: 6.0%) compared with those 5-11 (2.0%; 2.1%) and 12-17 years of age (2.2%; 2.5%). In the hospitalized cohort, mean (SD) length of stay was longer [5.0 (5.8) days] among those 12-17 years old (n = 24) than those 1-4 [n = 15; 1.8 (0.9) days] and 5-11 years old [n = 21; 2.8 (2.1) days]. Most pediatrics diagnosed with COVID-19 were managed in the community. However, hospitalizations were an important driver of HCRU and costs, particularly for those 12-17 years old. Our results may help optimize the management and resource allocation of COVID-19 in this population.
Sections du résumé
BACKGROUND
BACKGROUND
Although COVID-19 morbidity is significantly lower in pediatrics than in adults, the risk of severe COVID-19 may still pose substantial health care resource burden. This study aimed to describe health care resource utilization (HCRU) and costs associated with COVID-19 in pediatrics 1-17 years old in England.
METHODS
METHODS
A population-based retrospective cohort study of pediatrics with COVID-19 using Clinical Practice Research Datalink (CPRD Aurum) primary care data and, where available, linked Hospital Episode Statistics Admitted Patient Care secondary care data. HCRU and associated costs to the National Health Service were stratified by age, risk of severe COVID-19 and immunocompromised status, separately for those with and without hospitalization records (hospitalized cohort: COVID-19 diagnosis August 2020-March 2021; primary care cohort: COVID-19 diagnosis August 2020-January 2022).
RESULTS
RESULTS
This study included 564,644 patients in the primary care cohort and 60 in the hospitalized cohort. Primary care consultations were more common in those 1-4 years of age (face-to-face: 4.3%; telephone: 6.0%) compared with those 5-11 (2.0%; 2.1%) and 12-17 years of age (2.2%; 2.5%). In the hospitalized cohort, mean (SD) length of stay was longer [5.0 (5.8) days] among those 12-17 years old (n = 24) than those 1-4 [n = 15; 1.8 (0.9) days] and 5-11 years old [n = 21; 2.8 (2.1) days].
CONCLUSIONS
CONCLUSIONS
Most pediatrics diagnosed with COVID-19 were managed in the community. However, hospitalizations were an important driver of HCRU and costs, particularly for those 12-17 years old. Our results may help optimize the management and resource allocation of COVID-19 in this population.
Identifiants
pubmed: 38113517
doi: 10.1097/INF.0000000000004213
pii: 00006454-990000000-00672
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.
Références
Gupta M, Gupta N, Esang M. Long COVID in children and adolescents. Prim Care Companion CNS Disord. 2022;24:21r03218.
Thelwall S, Aiano F, Harman K, et al. Risk of hospitalisation and death in children with SARS-CoV-2 delta (B16122) infection. Lancet Child Adolesc Health. 2022;6:e16–e17.
GOV.UK. England Summary - Coronavirus (COVID-19). London: GOV.UK; 2023 [April 24, 2023]. Available at: https://coronavirus.data.gov.uk/. Accessed April 23, 2023.
Antoon JW, Hall M, Howard LM, et al. COVID-19 and acute neurologic complications in children. Pediatrics. 2022;150:e2022058167.
Di Fusco M, Vaghela S, Moran MM, et al. COVID-19-associated hospitalizations among children less than 12 years of age in the United States. J Med Econ. 2022;25:334–346.
Gotzinger F, Santiago-Garcia B, Noguera-Julian A, et al.; ptbnet COVID-19 Study Group. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health. 2020;4:653–661.
CDC. Coronavirus disease 2019 in children - United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:422–426.
Swann OV, Holden KA, Turtle L, et al.; ISARIC4C Investigators. Clinical characteristics of children and young people admitted to hospital with COVID-19 in United Kingdom: prospective multicentre observational cohort study. BMJ. 2020;370:m3249.
Woodruff RC, Campbell AP, Taylor CA, et al. Risk factors for severe COVID-19 in children. Pediatrics. 2022;149:e2021053418.
Tsankov BK, Allaire JM, Irvine MA, et al. Severe COVID-19 infection and pediatric comorbidities: a systematic review and meta-analysis. Int J Infect Dis. 2021;103:246–256.
National Audit Office. The rollout of the COVID-19 vaccination programme in England. London; 2022.
NHS England. NHS rolls out COVID vaccine to five million 5 to 11 year olds. London. 2022 [cited May 02, 2023]. Available at: https://www.england.nhs.uk/2022/04/nhs-rolls-out-covid-vaccine-to-five-million-5-to-11-year-olds/. Accessed June 5, 2023.
GOV.UK. Children aged 6 months to 4 years in clinical risk groups to be offered COVID-19 vaccine, says JCVI. London: GOV.UK; 2023 [June 6, 2023]. Available at: https://www.gov.uk/government/news/children-aged-6-months-to-4-years-in-clinical-risk-groups-to-be-offered-covid-19-vaccine-says-jcvi#:~:text=Committee%20recommends%20COVID%2D19%20vaccine%20for%20children%20with%20underlying%20medical%20conditions.&text=The%20Joint%20Committee%20on%20Vaccination,(COVID%2D19)%20vaccine. Accessed June 5, 2023.
ONS. Coronavirus (COVID-19) vaccination uptake in school pupils, England: up to 22 July 2022: Office for National Statistics. 2022 [cited April 24, 2023]. Available at: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandwellbeing/articles/coronaviruscovid19vaccinationuptakeinschoolpupilsengland/upto22july2022. Accessed April 24, 2023.
Pike J, Kompaniyets L, Lindley MC, et al. Direct medical costs associated with post-COVID-19 conditions among privately insured children and adults. Prev Chronic Dis. 2023;20:E06.
Hoehl S, Schneider F, Eckrich M, et al. COVID-19 among children seeking primary paediatric care with signs of an acute infection. Acta Paediatr. 2021;110:3315–3321.
Clinical Practice Research Datalink (CPRD). CPRD Aurum. March 2022(Version 2022.03.001) [Data set] . Clinical Practice Research Datalink; 2022 [March 9, 2023].Available at: https://doi.org/10.48329/MY9S-4X08. Accessed March 9, 2023.
Clinical Practice Research Datalink (CPRD). CPRD linked data. 2022 [March 9, 2023]. Available at: https://cprd.com/cprd-linked-data. Accessed March 9, 2023.
Clinical Practice Research Datalink (CPRD). Release notes: CPRD Aurum. May 2022 [March 9, 2023]. Available at: https://cprd.com/sites/default/files/2022-05/2022-05%20CPRD%20Aurum%20Release%20Notes.pdf. Accessed March 9, 2023.
Clinical Practice Research Datalink (CPRD). Feasibility counts for SARS-CoV-2-related codes in CPRD primary care data. May 2022 [March 9, 2023]. Available at: https://cprd.com/sites/default/files/2022-05/SARS-CoV-2%20counts%20May2022.pdf. Accessed March 9, 2023.
Andersen KM, McGrath LJ, Reimbaeva M, et al. Persons diagnosed with COVID in England in the Clinical Practice Research Datalink (CPRD): A cohort description. medRxiv; 2023.
Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130–1139.
Davidson JA, Banerjee A, Smeeth L, et al. Risk of acute respiratory infection and acute cardiovascular events following acute respiratory infection among adults with increased cardiovascular risk in England between 2008 and 2018: a retrospective, population-based cohort study. Lancet Digit Health. 2021;3:e773–e783.
World Health Oganization (WHO). COVID-19 Therapeutic Trial Synopsis. 2020 [March 9, 2023]. Available at: https://www.who.int/publications/i/item/covid-19-therapeutic-trial-synopsis. Accessed March 9, 2023.
National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: Managing COVID-19 [May 2022 (V24.0)]. Available at: Guideline COVID-19 rapid guideline: Managing COVID-19 (nice.org.uk). Accessed June, 2022.
NHS England. UK Interim Clinical Commissioning Policy: Therapies for symptomatic non-hospitalised patients with COVID-19. London: NHS England; 2021 [June 5, 2023]. Available at: https://www.health-ni.gov.uk/publications/interim-clinical-commissioning-policy-neutralising-monoclonal-antibodies-or-antivirals-non. Accessed June 5, 2023.
NHS England. National Cost Collection for the NHS 2020/2021. 2021 [March 9, 2023]. Available at: https://www.england.nhs.uk/costing-in-the-nhs/national-cost-collection/. Accessed March 9, 2023.
NHS Digital. HRG4 + 2021/22 National Costs Grouper. London: NHS Digital; 2022 [June 5, 2023]. Available at: https://digital.nhs.uk/services/national-casemix-office/downloads-groupers-and-tools/hrg4-2021-22-national-costs-grouper. Accessed June 5, 2023.
NHS Digital. Hospital Admitted Patient Care Activity 2020-21. September 16, 2021 [March 14, 2023]. Available at: https://digital.nhs.uk/data-and-information/publications/statistical/hospital-admitted-patient-care-activity/2020-21. Accessed March 14, 2023.
Personal Social Services Research Unit (PSSRU). Unit Costs of Health and Social Care. 2022 [March 9, 2023]. Available at: https://www.pssru.ac.uk/project-pages/unit-costs/. Accessed March 9, 2023.
NHS Business Services Authority (NHSBSA). Drug Tariff. 2022 [March 9, 2023]. Available at: https://www.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance-contractors/drug-tariff. Accessed March 9, 2023.
Intensive Care National Audit and Research Centre (ICNARC). COVID-19 Report. 2023 [March 14, 2023]. Available at: https://www.icnarc.org/our-audit/audits/cmp/reports. Accessed March 14, 2023.
Ioannou GN, Locke E, Green P, et al. Risk factors for hospitalization, mechanical ventilation, or death among 10 131 US veterans with SARS-CoV-2 Infection. JAMA Netw Open. 2020;3:e2022310–e20210-e.
UK Health Security Agency (UKHSA). COVID-19: the Green Book, chapter 14a. 2022: 1–54 [March 9, 2023]. Available at: https://www.gov.uk/government/publications/covid-19-the-green-book-chapter-14a. Accessed March 9, 2023.
Foley KA, Maile EJ, Bottle A, et al. Impact of COVID-19 on primary care contacts with children and young people in England: longitudinal trends study 2015-2020. Br J Gen Pract. 2022;72:e464–e471.
Ruzangi J, Blair M, Cecil E, et al. Trends in healthcare use in children aged less than 15 years: a population-based cohort study in England from 2007 to 2017. BMJ Open. 2020;10:e033761.
Vestesson EM, De Corte KLA, Crellin E, et al. Consultation rate and mode by deprivation in English general practice from 2018 to 2022: population-based study. JMIR Public Health Surveill. 2023;9:e44944.
Halls A, Van’t Hoff C, Little P, et al. Qualitative interview study of parents’ perspectives, concerns and experiences of the management of lower respiratory tract infections in children in primary care. BMJ Open. 2017;7:e015701.
The Health Foundation. Non-COVID-19 NHS care during the pandemic - Activity trends for key NHS services in England. December 12, 2020 [March 13, 2023]. Available at: https://www.health.org.uk/news-and-comment/charts-and-infographics/non-covid-19-nhs-care-during-the-pandemic. Accessed March 13, 2023.
Ahmed S, Sanghvi K, Yeo D. Telemedicine takes centre stage during COVID-19 pandemic. BMJ Innov. 2020;6:252–254.
National Institute for Health and Care Research. How have GP practices adapted to the COVID-19 pandemic? 2020 [March 13, 2023]. Available at: https://arc-w.nihr.ac.uk/research/projects/collecting-rapid-covid-19-intelligence-to-improve-primary-care-response/. Accessed March 13, 2023.
The Health Foundation. Public confidence in using NHS returning but concerns persist among groups worst affected by COVID-19. September 10, 2020 [March 13, 2023]. Available at: https://www.health.org.uk/news-and-comment/news/public-confidence-in-using-nhs-returning-but-concerns-persist. Accessed March 13, 2023.
The Health Foundation. How has the COVID-19 pandemic impacted primary care? May 27, 2021 [March 13, 2023]. Available at: https://www.health.org.uk/news-and-comment/charts-and-infographics/how-has-the-covid-19-pandemic-impacted-primary-care. Accessed March 13, 2023.
Dorfman L, Nassar R, Binjamin Ohana D, et al. Pediatric inflammatory bowel disease and the effect of COVID-19 pandemic on treatment adherence and patients’ behavior. Pediatr Res. 2021;90:637–641.
Dorfman L, Nassar R, Rozenfeld Bar-Lev M, et al. Treatment adherence and behavior of pediatric liver transplant recipients during the COVID-19 pandemic. Pediatr Transplant. 2022;26:e14250.
Yang J, Anderson MK, Rai KK, et al. Healthcare resource utilisation and costs of hospitalisation and primary care among adults with COVID-19 in England: a population-based cohort study. medRxiv; 2023.
Chappell H, Patel R, Driessens C, et al. Immunocompromised children and young people are at no increased risk of severe COVID-19. J Infect. 2022;84:31–39.
Neill S, Roland D, Thompson M, et al. Why are acute admissions to hospital of children under 5 years of age increasing in the UK? Arch Dis Child. 2018;103:917–919.
Ward JL, Harwood R, Smith C, et al. Risk factors for PICU admission and death among children and young people hospitalized with COVID-19 and PIMS-TS in England during the first pandemic year. Nat Med. 2022;28:193–200.
Thom H, Walker J, Vickerman P, et al. Exploratory comparison of healthcare costs and benefits of the UK’s COVID-19 response with four European countries. Eur J Public Health. 2021;31:619–624.
Public Health England. Weekly national flu reports: 2019 to 2020 season. London: GOV.UK; 2019 [June 5, 2023]. Available at: https://www.gov.uk/government/statistics/weekly-national-flu-reports-2019-to-2020-season. Accessed June 5, 2023.
Nathanielsz J, Toh ZQ, Do LAH, et al. SARS-CoV-2 infection in children and implications for vaccination. Pediatr Res. 2022;93:1177–1187.
Wang L, Berger NA, Kaelber DC, et al. Incidence rates and clinical outcomes of SARS-CoV-2 infection with the omicron and delta variants in children younger than 5 years in the US. JAMA Pediatr. 2022;176:811–813.
Nyberg T, Ferguson NM, Nash SG, et al.; COVID-19 Genomics UK (COG-UK) consortium. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet. 2022;399:1303–1312.
Nobari H, Fashi M, Eskandari A, et al. Effect of COVID-19 on health-related quality of life in adolescents and children: a systematic review. Int J Environ Res Public Health. 2021;18:4563.
Department for Education. The link between absence and attainment at KS2 and KS4. London: Department for Education; 2016.
Silverberg SL, Zhang BY, Li SNJ, et al. Child transmission of SARS-CoV-2: a systematic review and meta-analysis. BMC Pediatr. 2022;22:172.
Carlton EF, Donnelly JP, Prescott HC, et al.; RESTORE Study Investigators. School and work absences after critical care hospitalization for pediatric acute respiratory failure: a secondary analysis of a cluster randomized trial. JAMA Netw Open. 2021;4:e2140732.